[PDF][PDF] Differential urinary proteomic analysis of endometrial cancer

M Kacírová, P Bober, M Alexovič, Z Tomková… - Physiological …, 2019 - researchgate.net
Endometrial cancer is one of the most frequent gynecological malignancies present in more
than 95% of all uterine cancers. In spite of that, screening of such disease is not commonly …

Tumor proteomics by multivariate analysis on individual pathway data for characterization of vulvar cancer phenotypes

AS Sandberg, G Lindell, BN Källström… - Molecular & Cellular …, 2012 - ASBMB
Vulvar squamous cell carcinoma (VSCC) is the fourth most common gynecological cancer.
Based on etiology VSCC is divided into two subtypes; one related to high-risk human …

Integrative approach: Advancing endometrial cancer biomarkers through machine learning and network-derived RNA-Seq screening

S Suman, A Kulshrestha - Human Gene, 2024 - Elsevier
The study aims to identify potential RNA biomarkers for progressive endometrial cancer with
a machine learning-based approach. High throughput screening of RNA-Seq expression …

Differential proteome profiling of eutopic endometrium from women with endometriosis to understand etiology of endometriosis

P Rai, V Kota, M Deendayal… - Journal of proteome …, 2010 - ACS Publications
The identification of molecular differences in the endometrium of women with endometriosis
is an important step toward understanding the pathogenesis of this condition and for …

Quantitative proteome profiling of human myoma and myometrium tissue reveals kinase expression signatures with potential for therapeutic intervention

S Lemeer, AM Gholami, Z Wu, B Kuster - Proteomics, 2015 - Wiley Online Library
Uterine leiomyomas are benign tumors affecting a large proportion of the female population.
Despite the very high prevalence, the molecular basis for understanding the onset and …

[PDF][PDF] A metabolomic signature of FIGO stage I and II endometrial cancer

M Gu, X Chen, Y Sun, L Wang, H Shu, C Qian - Neoplasma, 2021 - researchgate.net
Endometrial cancer (EC) is a malignant tumor of the female reproductive tract. Due to its
rapid growth and invasiveness, EC is currently the only gynecological neoplasm with rising …

[PDF][PDF] Endometrial cancer and application of proteomics

S Attarha, M Mints, S Andersson… - Experimental …, 2011 - researchgate.net
Endometrial cancer (EC) is the fourth most common type of cancer among women and the
most common gynecologic malignancy which accounts for 6% of all cancers in females …

In silico approach for validating and unveiling new applications for prognostic biomarkers of endometrial cancer

E Coll-de La Rubia, E Martinez-Garcia, G Dittmar… - Cancers, 2021 - mdpi.com
Simple Summary Endometrial cancer (EC) mortality is directly associated with the presence
of poor prognostic factors. Molecular prognostic factors have been identified, but none are …

Identification of key candidate genes and pathways in endometrial cancer: Evidence from bioinformatics analysis

S Lv, X Xu, Z Wu - Oncology Letters, 2019 - spandidos-publications.com
Endometrial cancer (EC) is the fourth most common cancer in women worldwide. Although
researchers are exploring the biological processes of tumorigenesis and development of …

Development of multimarker panel for early detection of endometrial cancer. High diagnostic power of prolactin

Z Yurkovetsky, S Ta'asan, S Skates, A Rand… - Gynecologic …, 2007 - Elsevier
OBJECTIVE.: Endometrial carcinoma is the most common gynecologic cancer. Although the
prognosis for endometrial cancer is generally good, cancers identified at late stages are …